Skip to main content
. 2023 Mar 11;20(6):4979. doi: 10.3390/ijerph20064979

Table 1.

AIS characteristics of the clusters (n = 29,384 AIS episodes).

All (n = 29,384) Cluster 1 (n = 9116) Cluster 2 (n = 13,330) Cluster 3 (n = 6825) p-Value *
Age, median (IQR) 68.4
(58.7–78.3)
68.7
(58.7–78.5)
68.0
(58.4–77.9)
68.6
(59.4–78.7)
<0.001
Male, n (%) 17,165 (58.4) 5320 (58.4) 7812 (58.6) 3967 (58.1) 0.800
Ethnicity, n (%)
Chinese 22,136 (75.3) 6940 (76.1) 9913 (74.4) 5187 (76.0) 0.056
Malay 4731 (16.1) 1429 (15.7) 2220 (16.7) 1071 (15.7)
Indian 2021 (6.9) 603 (6.6) 964 (7.2) 449 (6.6)
History of stroke/TIA, n (%) 7883 (48.2) 2490 (48.5) 3568 (48.2) 1795 (48.0) 0.867
History of IHD/AF/VHD/PVD, n (%) 9328 (51.7) 2949 (52.6) 4143 (51.2) 2197 (51.2) 0.223
History of diabetes, n (%) 11,474 (56.8) 3511 (56.5) 5259 (57.2) 2659 (56.3) 0.503
History of hypertension, n (%) 22,744 (82.9) 7109 (83.2) 10,241 (82.3) 5312 (83.6) 0.075
History of hyperlipidaemia, n (%) 18,490 (75.3) 5783 (75.7) 8241 (74.7) 4393 (76.0) 0.133
Current/former smoker, n (%) 11,673 (41.0) 3621 (41.0) 5367 (41.6) 2637 (39.7) 0.043
Survived to hospital discharge, n (%) 27,641 (94.1) 8548 (93.8) 12,557 (94.2) 6431 (94.2) 0.334

* Kruskal–Wallis test was used to obtain the p-values. IQR: interquartile range; TIA: transient ischaemic attack; IHD: ischaemic heart disease; AF: atrial fibrillation; VHD: valvular heart disease; PVD: peripheral vascular disease.